Embecta Corp.: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value and what the price assumes
Average of FY2023–FY2025 (cash from operations less capital spending), from the statements below.
Starts at revenue growth over the last three years, -1.5% a year (statements).
US Treasury 10-year yield on Nov 13, 2026: 5.15% (US Treasury).
Your assumption: the extra yearly return you want for holding shares rather than Treasuries. 5% is a round starting figure, not data.
Your assumption: long-run growth, usually near inflation. It must stay below the discount rate.
Debt less cash at the end of FY2025 (statements); negative means more cash than debt.
What today's price assumes
A market value of $366 M means free cash flow growing 7.3% a year for 10 years, then 2.5% for ever, at a 10.15% discount rate.
Revenue grew -1.5% a year over the last three years.
Against the market value, for other rates
Cash-flow value of the shares as a percentage above or below today's market value; your inputs in the middle.
| Discount rate ↓ / growth → | -6.47% | -3.97% | -1.47% | 1.03% | 3.53% |
|---|---|---|---|---|---|
| 8.15% | -218% | -176% | -124% | -61% | +15% |
| 9.15% | -243% | -208% | -166% | -114% | -51% |
| 10.15% | -262% | -232% | -197% | -153% | -100% |
| 11.15% | -277% | -251% | -220% | -183% | -138% |
| 12.15% | -289% | -266% | -239% | -207% | -168% |
On one scale
Bars: from the 25th to the 75th percentile multiple of the peers, the line at the median; dot: the cash-flow value with your inputs.
Your own DCF model
A full discounted-cash-flow model of Embecta Corp., started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelAgainst the sector Healthcare
Multiples of its companies with a market value at most 60 days old, times Embecta Corp.'s own figures of FY2025.
| Multiple | Peers (25th / median / 75th) | Embecta Corp. | Applied to | Value (25th to 75th) | Companies |
|---|---|---|---|---|---|
| P/E | 18.5× / 30.2× / 54.0× | 4.2× | net income $95 M | $1.8 B to $5.1 B | 218 |
| Price to sales | 1.3× / 2.8× / 6.7× | 0.4× | revenue $1.1 B | $1.4 B to $7.2 B | 353 |
Peers' multiples from the distributions by industry; the company's figures from its statements below. A multiple says what similar companies cost, not what this one is worth.
Against its own history
Embecta Corp.'s multiples at each month end with a market cap on file, Dec 2022 to Oct 2026, each against its own median.
P/E
4.2×Now below its median of 8.7×; range 1.7× to 15.3× over 27 months.
Price to sales
0.4×Now below its median of 0.6×, in the bottom quarter of its range; range 0.2× to 1.4× over 27 months.
as of Oct 29, 2026. Market caps: the dated values on file since 2020, and in between the SEC's fails-to-deliver closing price times the share count on the latest 10-K or 10-Q cover. Each month divides by the last twelve months' results that had been published by then (a quarter 45 days after it ended, a fiscal year 60 days after), so the past is not read with figures that came out later; months with a loss give no P/E. Newest month: Oct 29, 2026.
The statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2025to Sep 30, 2025 | $1.1 B | $95 M | $192 M | $9 M | $182 M | $1.2 B | SEC annual report (10-K, 20-F) |
| FY2024to Sep 30, 2024 | $1.1 B | $78 M | $36 M | $16 M | $20 M | $1.3 B | SEC annual report (10-K, 20-F) |
| FY2023to Sep 30, 2023 | $1.1 B | $70 M | $68 M | $27 M | $41 M | $1.3 B | SEC annual report (10-K, 20-F) |
| FY2022to Sep 30, 2022 | $1.1 B | $224 M | $412 M | $24 M | $389 M | $1.3 B | SEC annual report (10-K, 20-F) |
| FY2021to Sep 30, 2021 | $1.2 B | $415 M | $456 M | $37 M | $420 M | $0 M | SEC annual report (10-K, 20-F) |
| FY2020to Sep 30, 2020 | $1.1 B | $428 M | $499 M | $42 M | $457 M | — | SEC annual report (10-K, 20-F) |
Each figure as filed; the full statements with every line and its filing are on the company page. Market value $366 M on Oct 29, 2026.
How it is worked out: the cash-flow value is free cash flow grown at the first-stage rate for the years chosen, then at the long-run rate for ever, each year discounted at the risk-free rate plus the equity risk premium, less net debt. What the price assumes is the first-stage growth that makes that value equal today's market value. The starting cash flow, growth and net debt come from the statements; the risk-free rate from the US Treasury; the premium and the long-run growth are assumptions and are labelled so. This is arithmetic on reported figures, not advice.